For B2B procurement managers in the global pet health industry—including brand distributors, OEM/ODM manufacturers, kennel chains, and veterinary retailers—maintaining long-term hormonal balance in adult pets has become a critical market priority. Hormonal fluctuations in dogs and cats often lead to erratic behavior, estrus-related disruptions, post-sterilization complications, and reduced quality of life, creating unmet demand for safe, natural, and sustainable daily care solutions. Yipai Biotechnology addresses this gap with the Daily Pet Hormone Balance Formula: a specialized supplement engineered for long-term endocrine support, combining Traditional Chinese Medicine (TCM) wisdom with cutting-edge biotechnology—designed to meet the rigorous standards of international B2B partners. Unlike short-term Pet Estrus Suppression Supplements, this formula delivers daily, gentle hormonal regulation without synthetic hormones, integrating Yipai’s signature Reishi Mushroom for Pets extract and advanced enzymolysis technology. It forms a core part of our Pet Ganoderma Nutritional Supplement series, complementing our full range of Veterinary supplements to provide holistic endocrine care. For B2B buyers, it offers three non-negotiable advantages: long-term safety, proven efficacy in behavioral and physiological regulation, and scalable supply—k

For B2B procurement managers in the global pet health industry—including specialty retailers, veterinary distributors, OEM/ODM manufacturers, and pet product wholesalers—addressing chronic liver disease in companion animals has become a high-priority market need. Chronic liver conditions (fatty liver, hepatitis, cirrhosis) affect millions of pets worldwide, particularly senior animals and breeds prone to hepatic issues, creating demand for science-backed, vet-recommended liver support solutions. Yipai Biotechnology responds with the Chronic Liver Care Supplement for Pets (Yigan Peptide): a specialized detox formula engineered to support long-term liver health, combining Traditional Chinese Medicine (TCM) wisdom with cutting-edge biotechnology—designed to meet the rigorous standards of international B2B partners. Unlike generic Pet Liver Supplements, this formula is exclusively optimized for chronic liver management, integrating Yipai’s patented Ganoderma lucidum extract (Patent No. 202110933638.0) and advanced enzymolysis technology. It delivers targeted support for liver detoxification, cellular repair, and immune enhancement—critical for pets with persistent hepatic conditions. For B2B buyers, it offers three non-negotiable advantages: clinical efficacy (backed by TCM and modern science), global quality certification, and scalable supply—key drivers of profitabili

For B2B procurement managers in the global veterinary industry—including veterinary oncology clinics, specialty pet hospitals, OEM/ODM manufacturers, and animal health distributors—providing science-backed nutritional support for pets with cancer has become a critical market priority. Cancer treatment (chemotherapy, radiation, surgery) in companion animals often leads to severe side effects: appetite loss, immune suppression, weight loss, and reduced quality of life. Yipai Biotechnology addresses this gap with the Cancer Treatment Support for Pets: a natural, clinical-strength supplement engineered to complement veterinary oncology care, combining Traditional Chinese Medicine (TCM) wisdom with cutting-edge biotechnology—designed to meet the rigorous standards of international B2B partners. Unlike generic Pet specialty oral vitamins, this formula is exclusively optimized for cancer-affected pets, integrating Yipai’s patented Reishi Mushroom with Vitamin A for Pets complex and advanced enzymolysis technology. It delivers dual-action support: immune modulation to combat cancer-related suppression and targeted nutrition to address treatment-induced deficiencies. For B2B buyers, it offers three non-negotiable advantages: clinical relevance (backed by patents and veterinary data), global quality certification, and seamless integration into oncology protocols—key drivers of

For B2B procurement managers in the global veterinary industry—including veterinary clinic chains, specialty pet hospitals, OEM/ODM manufacturers, and animal health distributors—providing safe, effective burn care solutions for pets has become a critical priority. Burn injuries (thermal, chemical, electrical) in companion animals require targeted nutritional support to accelerate tissue regeneration, reduce recovery time, and prevent complications. Yipai Biotechnology addresses this gap with the Burn Care Vitamin B1 for Pets (Yi B1 Peptide Oral Liquid): a veterinary-exclusive supplement engineered to meet the rigorous demands of clinical burn care, combining patented technology with therapeutic-grade ingredients—designed for B2B partners seeking reliable, high-margin products. Unlike generic Pet specialty oral vitamins, this formula is specifically optimized for burn recovery, integrating Yipai’s proprietary Reishi Mushroom with Vitamin B1 for Pets complex and advanced enzymolysis technology. It delivers dual-action support: thiamine (Vitamin B1) for energy metabolism in healing cells, and Reishi mushroom for immune modulation—critical for immunocompromised burn patients. For B2B buyers, it offers three non-negotiable advantages: clinical safety (sterile formulation), proven efficacy (accelerated tissue regeneration), and global quality certification—key drivers of

For B2B procurement managers in the global pet health industry—including veterinary distributors, OEM/ODM manufacturers, specialty retailers, and breeding facilities—addressing pet cerebral ischemia has emerged as a high-priority market need. Cerebral ischemia (reduced blood flow to the brain) threatens companion animals with neurological damage, cognitive decline, and mobility loss, particularly in senior pets and breeds prone to vascular issues. Yipai Biotechnology responds with the Brain Support for Ischemic Pets: a clinically proven nutritional supplement engineered to target cerebral health, combining neuroprotective ingredients with advanced biotechnology—designed to meet the rigorous standards of international B2B partners. Unlike generic Cardiovascular support for animals, this formula is exclusively optimized for cerebral circulation and neural protection, integrating Yipai’s signature Reishi Mushroom for Pets technology (a core component of our Pet Ganoderma Nutritional Supplement line). It delivers dual value: resolving acute ischemia-related damage and supporting long-term cognitive health, aligning with the growing demand for advanced pet neurological care in欧美 markets. For B2B buyers, it offers three critical advantages: clinical efficacy (32% faster brain oxygen recovery), global quality certification, and seamless integration with ex

For B2B procurement managers in the global pet health industry—including veterinary distributors, OEM/ODM manufacturers, senior pet care facilities, and specialty retailers—addressing pet kidney health has become a critical market priority. Chronic kidney disease (CKD) affects up to 30% of senior pets, with breed-specific predispositions increasing demand for science-backed, vet-recommended renal support solutions. Yipai Biotechnology responds with the Advanced Renal Support for Pets: a high-tech nutritional supplement that merges Traditional Chinese Medicine (TCM) wisdom with cutting-edge biotechnology, engineered to meet the rigorous standards of international B2B partners. Unlike generic renal supplements, this formula delivers targeted support for kidney function, immune health, and nutrient absorption—critical for pets with compromised renal systems. As a core product in Yipai’s Pet Ganoderma Nutritional Supplement series, it integrates our patented Reishi Mushroom for Pets technology and advanced enzymolysis process, complementing our full range of Veterinary supplements to form a comprehensive renal care system. For B2B buyers, it offers three non-negotiable advantages: proven clinical relevance, global quality certification, and scalable supply—key drivers of profitable partnerships in the competitive pet health market. Below, we break down th

For B2B procurement managers in the global pet health industry—including brand distributors, OEM/ODM manufacturers, veterinary clinics, and breeding facilities—managing sexual hormone imbalances in adult pets has become a critical market priority. Hormonal fluctuations post-sexual maturity often lead to erratic behavior, heat cycle disruptions, post-sterilization complications, and reduced breeding efficiency, creating unmet demand for safe, natural, and science-backed solutions. Yipai Biotechnology addresses this gap with the Adult Pet Sex Hormone Balancer (Yiqing Peptide): a breakthrough formula merging Traditional Chinese Medicine (TCM) wisdom with cutting-edge enzymolysis technology, engineered to meet the rigorous standards of international B2B partners. Unlike synthetic hormone treatments with side effects, this supplement delivers holistic sex hormone regulation without harsh chemicals, aligning with the global shift toward natural pet care. As a core product in Yipai’s Pet Ganoderma Nutritional Supplement series, it integrates our signature Reishi Mushroom for Pets extract, complementing our full range of Veterinary supplements to form a comprehensive pet health system. For B2B buyers, it offers three non-negotiable advantages: proven efficacy, global quality certification, and scalable supply—key drivers of profitable partnerships in competitiv

For B2B procurement managers in the global pet health industry—including brand distributors, OEM/ODM manufacturers, veterinary clinics, and breeding facilities—managing endocrine disturbances in sexually mature pets has become a critical market priority. Hormonal imbalances post-sexual maturity often lead to erratic behavior, heat cycle disruptions, post-sterilization complications, and reduced breeding efficiency, creating unmet demand for safe, effective solutions. Yipai Biotechnology addresses this gap with the Adult Pet Hormone Balance Supplement (Yiqing Peptide): a GMP-certified, natural formula that combines Traditional Chinese Medicine (TCM) wisdom with cutting-edge technology, designed to meet the rigorous standards of international B2B partners. Unlike synthetic hormone regulators, this supplement delivers holistic endocrine support without harsh chemicals, aligning with the growing global demand for natural pet care. As a core product in Yipai’s Pet Ganoderma Nutritional Supplement line, it integrates our signature Reishi Mushroom for Pets extract, complementing our full range of Veterinary supplements to form a comprehensive pet health system. For B2B buyers, it offers three non-negotiable advantages: proven efficacy, global quality certification, and scalable supply—key drivers of profitable partnerships in competitive markets. Below, we bre

For B2B procurement managers in the global pet health industry—including brand distributors, OEM/ODM manufacturers, and veterinary clinic suppliers—addressing sexual maturity-related anorexia in adult pets has become a critical market demand. As pets reach sexual maturity, hormonal fluctuations, gastrointestinal dysfunction, and reduced nutrient absorption often lead to appetite loss, picky eating, and health decline—creating a gap in existing generic solutions. Yipai Biotechnology, a leader in evidence-based pet nutrition, introduces the Adult Pet Appetite Support Supplement: a natural, vet-approved formula designed to resolve the root causes of adult pet anorexia while meeting the rigorous standards of B2B wholesale partners. Unlike one-size-fits-all appetite stimulants, this product integrates Traditional Chinese Medicine (TCM) wisdom with cutting-edge pet nutrition technology, complementing Yipai’s Pet gastrointestinal support and Veterinary digestive aids to form a comprehensive care system. For B2B partners, it delivers three core values: differentiated market positioning (targeting sexual maturity-specific needs), proven efficacy (backed by patents and clinical application), and scalable supply capacity

As global demand for high-quality veterinary liver supplements surges, B2B procurement managers in the pet health industry are seeking innovative, science-backed solutions to meet market needs. Yipai Biotechnology, a leader in pet nutritional supplements, introduces Yigan Peptide - Liver Damage Repair Nutrients for Dogs and Cats – a breakthrough product in our Pet Ganoderma Nutritional Supplement series, designed to redefine liver support for companion animals. This patent-protected formula combines traditional Chinese medicine wisdom with cutting-edge biotechnology, addressing the unmet needs of manufacturers, distributors, and veterinary clinics worldwide. For B2B partners, this product represents more than a supplement – it’s a competitive edge in a growing market. With rising concerns over pet liver diseases (e.g., fatty liver, hepatitis, and drug-induced damage), the Liver Support Supplement for Dogs and Cats offers a unique value proposition: proven efficacy, patented ingredients, and scalable supply capabilities. Below, we break down the core advantages, technical specifications, and B2B collaboration benefits that matter most to procurement decision-makers.

Core Product Advantages for B2B Partners Patented & Clinically Proven Formulation Reishi Mushroom with Vitamin A for Pets: Ganoderma lucidum extract provides antioxidant and immune-modulating benefits, validated to reduce free radical damage by 42% in clinical trials. Fresh Meat Enzymolysis Technology: Converts proteins into small-molecule peptides (95% bioavailability) for pets with compromised digestive systems during cancer treatment. Clinical-Strength Pet Multivitamin: Dual-action formula addresses nutritional deficiencies and immune suppression—key challenges in pet oncology. Patented Innovation: Protected by Invention Patent No. 202110933638.0 for Ganoderma lucidum spore powder integration, ensuring unique market positioning. Global Quality Certifications: Manufactured in FDA-registered facility (Reg. No. 13323196228) with ISO 9001:2015 certification—compliant with EU/US standards. plaintext <h3 style="font-size: 18px; color: #2980b9; margin: 20px 0 15px;">B2B-Focused Supply & Customization</h3> <ul style="padding-left: 20px; margin-bottom: 20px;"> <li>Monthly production capacity of <strong>20,000 units</strong> to meet bulk order demands.</li> <li>Flexible OEM/ODM services: Formula adjustment, private labeling, and

Core Product Advantages for B2B Partners Advanced Joint Support Formula Blends glucosamine chondroitin for dogs and cats, MSM for pet joint inflammation, and bovine bone peptide to accelerate cartilage repair—critical for canine feline osteoarthritis management. plaintext <h3>TCM-Western Science Integration</h3> <p>Combines Ligusticum chuanxiong and Smilax glabra (TCM principles) with Western nutrition to reduce inflammation naturally, a unique selling point for health-conscious markets.</p> <h3>Proprietary Fresh Meat Enzymolysis Technology</h3> <p>Converts macromolecular proteins into small-molecule peptides, ensuring 95% bioavailability and minimal digestive burden—ideal for long-term use in pets with arthritis.</p> <h3>Complete Vitamin Profile for Holistic Health</h3> <p>Enriched with VA, VD3, VB6, VB12, VC, and choline to support joint health while boosting overall pet wellness, differentiating it from single-function supplements.</p> <h3>Reishi Mushroom & Vitamin B6 Enhancement</h3> <p>Features Yipai’s signature <strong>Reishi Mushroom with Vitamin B6 for Pets</strong> to add immune support and anti-inflammatory benefits, aligning with global “natural pet care” trends.</p> <h3>ISO & FDA-Certified Manufacturing</h3> <p>Produced in a 5,000㎡ facility with 6 automated lines (FDA Reg. No. 13323196228, ISO 9001:2015) — batch-to-batch consistency guaranteed for B2B supply chains.</p> Key Application Scenarios for B2B Partners Veterinary Clinics & Hospitals: Post-surgical joint recovery and osteoarthritis management for clinical settings. Pet Product Retailers: Geriatric joint ma